BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8066622)

  • 21. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic death induced in MOLT-4 T-lymphoblasts by purine nucleoside phosphorylase inhibition.
    Gilbertsen RB; Posmantur R; Nath R; Wang KK
    Inflamm Res; 1997 Aug; 46 Suppl 2():S151-2. PubMed ID: 9297556
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cellular interactions in immune responses].
    Tadakuma T
    Tanpakushitsu Kakusan Koso; 1987 Oct; 32(11):1285-90. PubMed ID: 2962230
    [No Abstract]   [Full Text] [Related]  

  • 24. Prednisone and T-cell subpopulations.
    Schuyler MR; Gerblich A; Urda G
    Arch Intern Med; 1984 May; 144(5):973-5. PubMed ID: 6231898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
    Miles EA; Banerjee T; Wells SJ; Calder PC
    Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and functional characterization of Eimeria tenella immune chicken T-cell clones.
    Bhogal BS; Schmatz DM; Tse HY; Ravino O; Jacobson EB
    Prog Clin Biol Res; 1987; 238():127-44. PubMed ID: 2955427
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of coffee cherry on the immune system in SHN mice.
    Kobayashi T; Yasuda M; Iijima K; Toriizuka K; Cyong JC; Nagasawa H
    Anticancer Res; 1996; 16(4A):1827-30. PubMed ID: 8712708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor cells of man.
    Ellner JJ
    Clin Immunol Rev; 1981; 1(1):119-214. PubMed ID: 6219849
    [No Abstract]   [Full Text] [Related]  

  • 29. The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor.
    Kimble E; Hadala J; Ludewig R; Peters P; Greenberg G; Xiao G; Guida W; McQuire L; Simon P
    Inflamm Res; 1995 Aug; 44 Suppl 2():S181-2. PubMed ID: 8548387
    [No Abstract]   [Full Text] [Related]  

  • 30. [The immune status in variants of the course and outcome of acute delta virus infection].
    Savitskiĭ GI; Khlopova IN; Zhilina NN; Malyshev NA; Ketiladze ES
    Ter Arkh; 1988; 60(11):19-22. PubMed ID: 2976991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage as a suppressor cell or a helper cell in human renal transplant patients.
    Kaneda I; Miura K; Sasaki T; Jimbo M; Satomi S; Okazaki H; Taguchi Y; Kasai M
    Transplant Proc; 1981 Mar; 13(1 Pt 1):678-81. PubMed ID: 6455810
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive activity of recombinant ILT3.
    Vlad G; Liu Z; Zhang QY; Cortesini R; Suciu-Foca N
    Int Immunopharmacol; 2006 Dec; 6(13-14):1889-94. PubMed ID: 17161342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of suppressor cells in cyclosporine-treated allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 9-benzyl-9-deazaguanine, a potent inhibitor of purine nucleoside phosphorylase, on the cytotoxicity and metabolism of 6-thio-2'-deoxyguanosine.
    Parker WB; Allan PW; Niwas S; Montgomery JA; Bennett LL
    Cancer Res; 1994 Apr; 54(7):1742-5. PubMed ID: 8137289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of T-lymphocyte and killer-cell defects in the pathogenesis of systemic lupus erythematodes].
    Wollina U
    Dermatol Monatsschr; 1983; 169(12):749-61. PubMed ID: 6230266
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of the neuromediator systems of the neostriatum on immunocompetent cells].
    Aliev NA
    Fiziol Zh SSSR Im I M Sechenova; 1988 Dec; 74(12):1738-42. PubMed ID: 2907493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.